Oncopharmpod
Cycling thru the CDK Inhibitors
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:18:28
- Mas informaciones
Informações:
Sinopsis
Abemaciclib's up-front approval provides an opportunity to review all 3 currently FDA-approved CDK 4/6 inhibitors. Dosing, drug interaction, and indication differences are discussed.
